Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Total Liabilities: 2015-2024

Historic Total Liabilities for Editas Medicine (EDIT) over the last 10 years, with Dec 2024 value amounting to $207.3 million.

  • Editas Medicine's Total Liabilities rose 23.93% to $188.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $188.3 million, marking a year-over-year increase of 23.93%. This contributed to the annual value of $207.3 million for FY2024, which is 38.16% up from last year.
  • Editas Medicine's Total Liabilities amounted to $207.3 million in FY2024, which was up 38.16% from $150.1 million recorded in FY2023.
  • Editas Medicine's Total Liabilities' 5-year high stood at $207.3 million during FY2024, with a 5-year trough of $123.8 million in FY2021.
  • For the 3-year period, Editas Medicine's Total Liabilities averaged around $170.3 million, with its median value being $153.6 million (2022).
  • In the last 5 years, Editas Medicine's Total Liabilities slumped by 30.82% in 2021 and then spiked by 38.16% in 2024.
  • Over the past 5 years, Editas Medicine's Total Liabilities (Yearly) stood at $179.0 million in 2020, then crashed by 30.82% to $123.8 million in 2021, then climbed by 24.06% to $153.6 million in 2022, then declined by 2.33% to $150.1 million in 2023, then skyrocketed by 38.16% to $207.3 million in 2024.